SUS for patients with atopic dermatitis | Brazil is obtained by full treatment by

Three ordinances were published on Tuesday (27) The official gazette of the union Extend to treatment Atopic dermatitis By a consolidated health system (Their). These documents officially make the merger in the public network of two skin ointment – Tacrolimo and Momatasone van – as well as the oral drug of the disease – methotrexate.

In a statement, the Ministry of Health has pointed out that the topical Tacrolimo and Momatasona van can be used to treat those who are unable to use corticosteroids or to treat those who have previously available treatments.

See more

“SUS patients are the relevant advantage of expanding access to Tacrolimo topical, because it is a high -cost medicine shadam, their access is more limited.”

According to the folder, methotrexate is indicated in cases of severe atopic dermatitis, especially in patients who cannot use cyclosporin, which is already available on a public network.

Understand

Non -calentagius disease, atopic dermatitis is characterized by genetic and chronic condition, mainly by severe itching and dry skin, especially in front of the body folds, elbows, such as knees and neck.

“This is one of the common forms of eczema, which is prevalent in childhood, although it can arise in adolescents or even in adolescence,” the ministry said

In young children, the face is also often affected by atopic dermatitis. “The disease is very different from the patient to the patient, with the folder added, with different extremes and reactions.”